Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.45
(
-1.59%
)
Bitcoin
75,624.13
(
-0.29%
)
News Focus
News Focus
Post# of 57984
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dominate post# 22220

Monday, 12/01/2008 5:52:37 PM

Monday, December 01, 2008 5:52:37 PM

Post# of 57984
>Johnson & Johnson Is Latest FDA Casualty<

Never mind the ceftobiprole rejection—JNJ’s executives are ecstatic today. They just acquired the best neurotoxin drug candidate and they didn’t have to overpay to get it.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today